TNM v1.8 changes:

  • Combined N adjusted to allow Path N to be cN0 for cancers with neo-adjuvant therapy where Regional Lymph Nodes were not examined (Regional LN Positive = 98). This is a special cases as Regional lymph node involvement is rare for these schema:
    • Bone
    • Corpus Adenosarcoma
    • Corpus Sarcoma
    • GIST Appendix
    • GIST Colon
    • GIST Esophagus
    • GIST Peritoneum
    • GIST Rectum
    • GIST Small Intestine
    • GIST Stomach
    • Melanoma Choroid
    • Melanoma Ciliary Body
    • Melanoma Iris
    • Retinoblastoma
    • Retroperitoneum
    • Soft Tissue
  • General: the link to the SEER Summary Stage 2000 in each schema was updated as the SEER website has been reorganized.